Advert Tech Briefing: Alphabet’s Q2 hints at ad tech’s declining profile in Google’s future

Advert Tech Briefing: Alphabet’s Q2 hints at ad tech’s declining profile in Google’s future

No matter mounting regulatory stress, analysts own few questions about the fate of Google’s core ad tech resources…
Learn Extra

More From Author

China Clinical Plan (867.HK, 8A8.SG) NDA for the Improved Original Drug ZUNVEYL for Alzheimer’s Disease Licensed in China

China Clinical Plan (867.HK, 8A8.SG) NDA for the Improved Original Drug ZUNVEYL for Alzheimer’s Disease Licensed in China

Fresh companion appointment marks a new chapter for Pentagram Fresh York

Fresh companion appointment marks a new chapter for Pentagram Fresh York

Leave a Reply

Your email address will not be published. Required fields are marked *